Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call Transcript [The Motley Fool]
Neurocrine Biosciences, Inc. (NBIX)
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
neurocrine.com/about-us/webcasts-presentations
Company Research
Source: The Motley Fool
NBIX earnings call for the period ending June 30, 2022.Image source: The Motley Fool.Neurocrine Biosciences(1.99%Aug 04, 20224:30 p.m. ETContents::OperatorGood day everyone, and welcome to today's Neurocrine Biosciences report second-quarter results. At this time all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. Please note today's call may be recorded and I will be standing by should you need any.It is now my pleasure to turn the conference over to the vice president of investor relations, Todd Tushla. Please go ahead.Todd FushlaVice President, Investor RelationsThank you, operator. Good afternoon, everyone, and welcome to our second quarter 2022 earnings call. With me are Kevin Gorman, our chief executive officer; Matthew Abernethy, our chief financial officer; Eiry Roberts, our chief medical officer; Eric Benevich, our chief commercial officer; and Kyle Gano, our chief business development and s
Show less
Read more
Impact Snapshot
Event Time:
NBIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBIX alerts
High impacting Neurocrine Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
NBIX
News
- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $148.00 to $158.00. They now have an "overweight" rating on the stock.MarketBeat
- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $170.00 to $200.00. They now have an "outperform" rating on the stock.MarketBeat
- Neurocrine Biosciences to Participate at Virtual Investor Conferences in MarchPR Newswire
- Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells Company Shares [Yahoo! Finance]Yahoo! Finance
NBIX
Earnings
- 2/7/24 - Beat
NBIX
Sec Filings
- 3/25/24 - Form 4
- 3/21/24 - Form 144
- 3/15/24 - Form 4
- NBIX's page on the SEC website